FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from [...]

TESCAN Launches AMBER 2: The Next Generation Gallium FIB-SEM

AMBER 2 debuts at M&M 2024 with New Tools for TEM Sample Preparation Brno, Czech Republic - TESCAN, a leading provider of scientific instrumentation, announces the launch of the TESCAN AMBER 2, the fourth generation of the TESCAN gallium FIB-SEM platform and the successor to the current AMBER generation, at the Microscopy & Microanalysis (M&M) Expo [...]

Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

SINGAPORE, Singapore -- Agilent Technologies Inc. (NYSE: A) today announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT). Agilent’s new protein analysis platform, an automated parallel capillary electrophoresis (CE) solution, combines rapid, high-resolution analysis with minimal sample consumption. This allows researchers to examine complex [...]

Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately

The patent at issue was ruled invalid by the German Federal Patent Court in May 2024 BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction that had been impacting sales of CosMx™ Spatial Molecular Imager (SMI) [...]

SPT Labtech’s firefly® chosen by PRISM BioLab to expedite discovery screening workflows

Placement of the first firefly platform in Japan expands SPT Labtech’s growing global liquid handling community. Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces the selection of its firefly all-in-one liquid handling platform by PRISM BioLab, a leading discovery [...]

Illumina Ventures Adds Two New Experts as Advisors

SAN FRANCISCO – Illumina Ventures, a leading genomics and precision health venture firm, today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team as Advisors. Together, they bring more than 60 years of executive leadership experience in molecular diagnostics and agribusinesses, respectively.    Dr. Stenzel is the former director of the US Food and [...]

Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries

Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the first patient has been dosed in Pure Biologics’ exploratory Phase [...]

Hamilton Company Unveils Two Revolutionary New Lab Solutions: Microlab Prep Automated Liquid Handler and the Prep CAP HEPA/UV

Microlab Prep with Clean Air Protection (CAP) RENO, NV - Hamilton Company, a global leader in the design and manufacture of liquid handling, process analytics, robotics and automated storage solutions, is excited to announce the launch of two innovative new products: the Microlab Prep with the new Prep Clean Air Protection (CAP) device. The Microlab Prep is a compact, [...]

CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts

New funding will expand CytoReason’s disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision. CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish an office in Cambridge, Massachusetts later [...]

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups OXFORD, England -- Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company's collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to [...]

Access IBO on Knowledge Center